African trypanosomiasis history and symptoms: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(13 intermediate revisions by 6 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{African trypanosomiasis}}
{{African trypanosomiasis}}
{{CMG}}; {{AOEIC}} Pilar Almonacid {{ADG}}
{{CMG}}; {{AOEIC}} Pilar Almonacid, {{ADG}}
==Overview==
==Overview==
The clinical course of human African trypanosomiasis has two stages. In the first stage, the [[Parasites|parasite]] is found in the peripheral circulation but it has not yet invaded the [[central nervous system]]. Once the [[Parasites|parasite]] crosses the [[blood-brain barrier]] and infects the [[central nervous system]], the [[disease]] enters the second stage. The subspecies that cause African trypanosomiasis have different rates of disease progression, and the clinical features depend on which form of the [[Parasites|parasite]] (T. b. rhodesiense or T. b. gambiense) is causing the infection. However, infection with either form will eventually lead to coma and death if not treated.<ref name="pmid19833383">{{cite journal |vauthors=Brun R, Blum J, Chappuis F, Burri C |title=Human African trypanosomiasis |journal=Lancet |volume=375 |issue=9709 |pages=148–59 |year=2010 |pmid=19833383 |doi=10.1016/S0140-6736(09)60829-1 |url=}}</ref><ref name="pmid17582444">{{cite journal |vauthors=Masocha W, Rottenberg ME, Kristensson K |title=Migration of African trypanosomes across the blood-brain barrier |journal=Physiol. Behav. |volume=92 |issue=1-2 |pages=110–4 |year=2007 |pmid=17582444 |doi=10.1016/j.physbeh.2007.05.045 |url=}}</ref><ref name="pmid18261232">{{cite journal |vauthors=Checchi F, Filipe JA, Haydon DT, Chandramohan D, Chappuis F |title=Estimates of the duration of the early and late stage of gambiense sleeping sickness |journal=BMC Infect. Dis. |volume=8 |issue= |pages=16 |year=2008 |pmid=18261232 |pmc=2259357 |doi=10.1186/1471-2334-8-16 |url=}}</ref><ref name="pmid9557424">{{cite journal |vauthors=Odiit M, Kansiime F, Enyaru JC |title=Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda |journal=East Afr Med J |volume=74 |issue=12 |pages=792–5 |year=1997 |pmid=9557424 |doi= |url=}}</ref>
The clinical course of human [[African trypanosomiasis]] has two stages. In the first stage, the [[Parasites|parasite]] is found in the peripheral [[circulation]] but it has not yet invaded the [[central nervous system]]. Once the [[Parasites|parasite]] crosses the [[blood-brain barrier]] and [[Infection|infects]] the [[central nervous system]], the [[disease]] enters the second stage. The [[subspecies]] that cause [[African trypanosomiasis]] have different rates of [[disease]] progression, and the clinical features depend on which form of the [[Parasites|parasite]] (''[[Trypanosoma brucei rhodesiense]]'' or ''[[Trypanosoma brucei gambiense]]'') is causing the [[infection]]. However, [[infection]] with either form will eventually lead to [[coma]] and death if not treated.
==History==
==History==
The significant information that needs to focused in the history of the patient includes
Obtaining the history is the most important aspect of making a diagnosis of African trypanosomiasis. It provides insight into cause, precipitating factors, and associated [[Comorbidity|comorbid]] conditions. A patient suffering from African trypanosimiasis may present with the following history:
*Any history of travel to the endemic areas
*Recent travel to the [[Endemic (epidemiology)|endemic]] areas
*Any ill contact with similar complaints
*Any ill contact with similar complaints


==Symptoms==
==Symptoms==
Symptoms of African trypanosomiasis include:<ref name="pmid19833383">{{cite journal |vauthors=Brun R, Blum J, Chappuis F, Burri C |title=Human African trypanosomiasis |journal=Lancet |volume=375 |issue=9709 |pages=148–59 |year=2010 |pmid=19833383 |doi=10.1016/S0140-6736(09)60829-1 |url=}}</ref><ref name="pmid17582444">{{cite journal |vauthors=Masocha W, Rottenberg ME, Kristensson K |title=Migration of African trypanosomes across the blood-brain barrier |journal=Physiol. Behav. |volume=92 |issue=1-2 |pages=110–4 |year=2007 |pmid=17582444 |doi=10.1016/j.physbeh.2007.05.045 |url=}}</ref><ref name="pmid18261232">{{cite journal |vauthors=Checchi F, Filipe JA, Haydon DT, Chandramohan D, Chappuis F |title=Estimates of the duration of the early and late stage of gambiense sleeping sickness |journal=BMC Infect. Dis. |volume=8 |issue= |pages=16 |year=2008 |pmid=18261232 |pmc=2259357 |doi=10.1186/1471-2334-8-16 |url=}}</ref><ref name="pmid9557424">{{cite journal |vauthors=Odiit M, Kansiime F, Enyaru JC |title=Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda |journal=East Afr Med J |volume=74 |issue=12 |pages=792–5 |year=1997 |pmid=9557424 |doi= |url=}}</ref>
[[Symptoms]] of African trypanosomiasis include:<ref name="pmid19833383">{{cite journal |vauthors=Brun R, Blum J, Chappuis F, Burri C |title=Human African trypanosomiasis |journal=Lancet |volume=375 |issue=9709 |pages=148–59 |year=2010 |pmid=19833383 |doi=10.1016/S0140-6736(09)60829-1 |url=}}</ref><ref name="pmid17582444">{{cite journal |vauthors=Masocha W, Rottenberg ME, Kristensson K |title=Migration of African trypanosomes across the blood-brain barrier |journal=Physiol. Behav. |volume=92 |issue=1-2 |pages=110–4 |year=2007 |pmid=17582444 |doi=10.1016/j.physbeh.2007.05.045 |url=}}</ref><ref name="pmid18261232">{{cite journal |vauthors=Checchi F, Filipe JA, Haydon DT, Chandramohan D, Chappuis F |title=Estimates of the duration of the early and late stage of gambiense sleeping sickness |journal=BMC Infect. Dis. |volume=8 |issue= |pages=16 |year=2008 |pmid=18261232 |pmc=2259357 |doi=10.1186/1471-2334-8-16 |url=}}</ref><ref name="pmid9557424">{{cite journal |vauthors=Odiit M, Kansiime F, Enyaru JC |title=Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda |journal=East Afr Med J |volume=74 |issue=12 |pages=792–5 |year=1997 |pmid=9557424 |doi= |url=}}</ref>
{| class="wikitable"
{| class="wikitable"
!Stages of infection
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Stages of infection
!Symptoms
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Symptoms
|-
|-
|Systemic
|[[Systemic]]
|
|
* [[Sweating]]
* [[Sweating]]
Line 24: Line 24:
|
|
* [[Headaches]]
* [[Headaches]]
* [[Joint pains]] and [[itching]]
* [[Myalgias]]
* [[Pruritis]]
|-
|-
|Second stage ([[neurological]] or [[Meningoencephalitis|meningoencephalic]] stage)
|Second stage ([[neurological]] or [[Meningoencephalitis|meningoencephalic]] stage)
|
|
* Changes of behaviour
* Changes in behavior
* [[Confusion]]
* [[Confusion]]
* Sensory disturbances   
* [[Sensory]] disturbances   
* Poor coordination
* Poor [[Motor coordination|coordination]]
* Disturbance of the sleep cycle
* Disturbance of the sleep cycle
|}
|}
The [[subspecies]] that cause African trypanosomiasis have different rates of [[disease]] progression, and the clinical features depend on which form of the [[Parasites|parasite]] (T. b. rhodesiense or T. b. gambiense) is causing the [[infection]].
The [[subspecies]] that cause [[African trypanosomiasis]] have different rates of [[disease]] progression and the clinical features depend on which form of the [[Parasites|parasite]] (''[[Trypanosoma brucei rhodesiense]]'' or ''[[Trypanosoma brucei gambiense]]'') is causing the [[infection]].


{| class="wikitable"
{| class="wikitable"
Line 54: Line 55:
|
|
* A  large sore (a [[chancre]]) will develop at the site of the [[Tsetse fly|tsetse]] bite
* A  large sore (a [[chancre]]) will develop at the site of the [[Tsetse fly|tsetse]] bite
* [[Fever]], [[headache]], [[muscle]] and [[joint aches]], and [[Enlarged lymph nodes|enlarged lymph node]]
* [[Fever]], [[headache]], [[muscle]] and [[joint aches]], and [[Enlarged lymph nodes|enlarged lymph nodes]]
|
|
* Mental deterioration and other [[Neurologic diseases|neurologic]] problems. Death ensues usually within months
* Mental deterioration and other [[Neurologic diseases|neurologic]] problems. Death ensues usually within months.
|-
|-
|West African sleeping sickness
|West African sleeping sickness
Line 64: Line 65:
(1-2 years)
(1-2 years)
|
|
* Intermittent [[fevers]], [[headaches]], [[muscle]] and [[joint aches]], and [[malaise]].
* Intermittent [[fevers]], [[headaches]], [[muscle]] and [[joint aches]], and [[malaise]]
* [[Itching]] of the skin, [[swollen lymph nodes]], and [[weight loss]]  
* [[Itching]] of the skin, [[swollen lymph nodes]], and [[weight loss]]  
|
|
* [[Personality changes]], [[daytime sleepiness]] with nighttime sleep disturbance, and progressive [[confusion]]
* [[Personality changes]], [[daytime sleepiness]] with nighttime sleep disturbance, and progressive [[confusion]].
* Other [[neurologic]] signs, such as partial [[paralysis]] or problems with [[Balance disorder|balance]] or walking may occur, as well as [[Hormonal|hormonal imbalances]]
* Other [[neurologic]] signs, such as partial [[paralysis]] or problems with [[Balance disorder|balance]] or walking may occur, as well as [[Hormonal|hormonal imbalances]].
* The course of untreated infection rarely lasts longer than 6-7 years and more often kills in about 3 years.
* The course of untreated infection rarely lasts longer than 6-7 years and more often kills in about 3 years.
|}
|}
Line 74: Line 75:
==References==
==References==
{{reflist|2}}
{{reflist|2}}
[[Category:Needs overview]]
 
[[Category:Needs content]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
 
[[Category:Disease]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Dermatology]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Emergency medicine]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Parasitic diseases]]
[[Category:Euglenozoa]]
[[Category:Sleep disorders]]
[[Category:Neglected diseases]]
[[Category:Insect-borne diseases]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 20:19, 29 July 2020

African trypanosomiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating African trypanosomiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT Scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

African trypanosomiasis history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of African trypanosomiasis history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on African trypanosomiasis history and symptoms

CDC on African trypanosomiasis history and symptoms

African trypanosomiasis history and symptoms in the news

Blogs on African trypanosomiasis history and symptoms

Directions to Hospitals Treating African trypanosomiasis

Risk calculators and risk factors for African trypanosomiasis history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Pilar Almonacid, Aditya Ganti M.B.B.S. [2]

Overview

The clinical course of human African trypanosomiasis has two stages. In the first stage, the parasite is found in the peripheral circulation but it has not yet invaded the central nervous system. Once the parasite crosses the blood-brain barrier and infects the central nervous system, the disease enters the second stage. The subspecies that cause African trypanosomiasis have different rates of disease progression, and the clinical features depend on which form of the parasite (Trypanosoma brucei rhodesiense or Trypanosoma brucei gambiense) is causing the infection. However, infection with either form will eventually lead to coma and death if not treated.

History

Obtaining the history is the most important aspect of making a diagnosis of African trypanosomiasis. It provides insight into cause, precipitating factors, and associated comorbid conditions. A patient suffering from African trypanosimiasis may present with the following history:

  • Recent travel to the endemic areas
  • Any ill contact with similar complaints

Symptoms

Symptoms of African trypanosomiasis include:[1][2][3][4]

Stages of infection Symptoms
Systemic
First stage (hemo-lyphatic stage)
Second stage (neurological or meningoencephalic stage)

The subspecies that cause African trypanosomiasis have different rates of disease progression and the clinical features depend on which form of the parasite (Trypanosoma brucei rhodesiense or Trypanosoma brucei gambiense) is causing the infection.

Disease Pathogen Geographic

distrubution

Progression Symptoms
First stage Second stage
East African sleeping sickness Trypanosoma brucei rhodesiense East and Southeast Africa Rapid

(1-2 weeks)

  • Mental deterioration and other neurologic problems. Death ensues usually within months.
West African sleeping sickness Trypanosoma brucei gambiense West and Central Africa Slow

(1-2 years)

References

  1. Brun R, Blum J, Chappuis F, Burri C (2010). "Human African trypanosomiasis". Lancet. 375 (9709): 148–59. doi:10.1016/S0140-6736(09)60829-1. PMID 19833383.
  2. Masocha W, Rottenberg ME, Kristensson K (2007). "Migration of African trypanosomes across the blood-brain barrier". Physiol. Behav. 92 (1–2): 110–4. doi:10.1016/j.physbeh.2007.05.045. PMID 17582444.
  3. Checchi F, Filipe JA, Haydon DT, Chandramohan D, Chappuis F (2008). "Estimates of the duration of the early and late stage of gambiense sleeping sickness". BMC Infect. Dis. 8: 16. doi:10.1186/1471-2334-8-16. PMC 2259357. PMID 18261232.
  4. Odiit M, Kansiime F, Enyaru JC (1997). "Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda". East Afr Med J. 74 (12): 792–5. PMID 9557424.


Template:WikiDoc Sources